Search results for "death"

showing 10 items of 1744 documents

Stroke in diabetic patients.

2011

Stroke is the leading cause of disability and the second most frequent cause of death worldwide. On the one hand, diabetic patients have a 1.5 to 3-times higher risk of stroke, especially cerebral infarction, than non-diabetic subjects. This excess risk, which is particularly pronounced in younger individuals and women, can be reduced by effective therapeutic strategies aimed at improving glycaemic control and the management of co-morbid conditions such as hypertension and dyslipidaemia. On the other hand, the prevalence of diabetes in stroke patients is between 10 and 20%, and has been increasing over the last 20 years, probably in response to rising rates of overweight and obesity in the …

Malemedicine.medical_specialtyLacunar strokeEndocrinology Diabetes and MetabolismPopulationDiabetes ComplicationsEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumanscardiovascular diseasesRisk factoreducationStrokeCause of deatheducation.field_of_studybusiness.industryCerebral infarctionAbsolute risk reductionGeneral Medicinemedicine.diseasePrognosisStrokePhysical therapyFemalebusinessDiabetesmetabolism
researchProduct

Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute hea…

2017

Aim: Baseline values of N-terminal pro B-type natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) predict all-cause mortality in acute heart failure (AHF). However, there is limited information about the added prognostic benefit of using longitudinal values, and how this predictive ability is modified when modelling together. The aim of this study was to determine the mutually-adjusted association between the longitudinal trajectories of NT-proBNP and CA125 with all-cause mortality after an episode of AHF. Methods and results: We included 946 consecutive patients discharged for AHF. NT-proBNP and CA125 were measured at each physician-patient encounter (median (interquartile…

Malemedicine.medical_specialtyLongitudinal studyTime Factorsacute heart failuremedicine.drug_class030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineRisk Assessment03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineCause of DeathNatriuretic Peptide BrainmedicineNatriuretic peptideHumans030212 general & internal medicineMortalitycarbohydrate antigen 125Survival rateCause of deathAgedRetrospective StudiesHeart Failurebusiness.industrylongitudinal studyMembrane ProteinsRetrospective cohort studyGeneral MedicineBrain natriuretic peptidemedicine.diseasePrognosisPeptide FragmentsSurvival RateEndocrinologyB-type natriuretic peptideSpainHeart failureCA-125 AntigenAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesEuropean heart journal. Acute cardiovascular care
researchProduct

Prediction of long-term major events soon after a first ST-segment elevation myocardial infarction by cardiovascular magnetic resonance.

2016

Cardiovascular magnetic resonance (CMR) predicts combined clinical events in post-ST-segment elevation myocardial infarction (STEMI) patients. However, its contribution to predicting long-term major events (ME: cardiac death and non-fatal myocardial infarction [MI]) is unknown. We aimed to assess whether CMR predicts long-term MEs when performed soon after STEMI.We prospectively recruited 546 STEMI patients between 2004 and 2012. The Left ventricular (LV) ejection fraction (LVEF,%), infarct size (IS), edema, hemorrhage, microvascular obstruction, and myocardial salvage were quantified by CMR at pre-discharge. During a mean follow-up of 840 days, 57 ME events (10%; 23 cardiac deaths, 34 non-…

Malemedicine.medical_specialtyMagnetic Resonance SpectroscopyMyocardial InfarctionHemorrhage030204 cardiovascular system & hematologyTime03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineEdemaInternal medicinemedicineST segmentEdemaHumansRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicineMyocardial infarctionProspective StudiesRegistriesEjection fractionmedicine.diagnostic_testClinical eventsbusiness.industryMyocardiumReproducibility of ResultsMagnetic resonance imagingGeneral MedicineMiddle AgedInfarct sizemedicine.diseaseMicrovesselscardiovascular systemCardiologyFemalemedicine.symptombusinessCardiac deathsFollow-Up StudiesEuropean journal of radiology
researchProduct

Association of total serum cholesterol with functional outcome following home care rehabilitation in Italian patients with stroke.

2012

Abstract Background Stroke is a disabling disease. In elderly populations, stroke is the third leading cause of death and the primary cause of reduction in or loss of functional ability and personal autonomy. Possible associations between levels of total serum cholesterol (TC) and both incidence of stroke and functional outcomes after rehabilitation are still under study. Objective To detect positive and negative prognostic factors associated with functional outcomes in first-time stroke patients admitted to an integrated home care rehabilitative program. Methods This study enrolled 141 patients with a first-time stroke who were admitted to a home care rehabilitation program. Primary outcom…

Malemedicine.medical_specialtyMultivariate analysisActivities of daily livingmedicine.medical_treatmentHealth StatusHypercholesterolemiaLogistic regressionSettore MED/42 - Igiene Generale E ApplicataSurveys and QuestionnairesActivities of Daily LivingOutcome Assessment Health CareMedicineHumansFunctional abilityMobility LimitationStrokeCause of deathAgedAged 80 and overRehabilitationbusiness.industryIncidence (epidemiology)Public Health Environmental and Occupational HealthAge FactorsStroke RehabilitationGeneral Medicinemedicine.diseasePrognosisHome Care ServicesStrokeCholesterolLogistic ModelsMental HealthTreatment OutcomeItalytotal cholesterol rehabilitation strocke functional outcomeMultivariate AnalysisPhysical therapyFemalebusinessDisability and health journal
researchProduct

Parkinson disease survival: a population-based study

2000

Objective To evaluate whether the survival of patients with Parkinson disease (PD) is shorter than that of the general population. Design Survival was investigated in a cohort of patients with PD previously identified during a population-based prevalence study (prevalence day, November 1, 1987; reference follow-up date, October 31, 1995). The survival of patients with PD was compared with that of a control sample randomly selected from the same population (2 controls for each case, matched for age, sex, and study municipality). The causes of death in the 2 groups were also compared. Both univariate and multivariate survival analyses were performed to investigate the association with disease…

Malemedicine.medical_specialtyMultivariate analysisHeart DiseasesPopulationComorbidityCohort StudiesLevodopaAge DistributionArts and Humanities (miscellaneous)Internal medicineCause of DeathmedicinePrevalenceHumansSex DistributioneducationSurvival rateSicilySurvival analysisCause of deathAgedProportional Hazards ModelsAged 80 and overUnivariate analysiseducation.field_of_studyNeuroscience (all)Proportional hazards modelbusiness.industryParkinson DiseasePneumoniaMiddle AgedSurvival AnalysisSurgerySurvival RateMultivariate AnalysisSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessCohort study
researchProduct

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from th…

2013

International audience; BACKGROUND: Lymphoma occurring in patients aged 90 or older is not uncommon, and its incidence is expected to increase over time. Management of these patients is difficult given their underlying fragility and the lack of information regarding this population. PATIENTS AND METHODS: We retrospectively analyzed 234 patients diagnosed with lymphoma at the age of 90 years or older (90+) between 1990 and 2012 to describe their characteristics, management, outcomes and prognostic factors. RESULTS: The median age was 92 years; 88% were B-cell lymphomas consisting mainly in diffuse large B-cell lymphoma. The median overall survival (OS) was 7.2 months (range, 0-92 months) for…

Malemedicine.medical_specialtyPalliative careSurvivalPopulation[SDV.CAN]Life Sciences [q-bio]/Cancerlymphoma[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciences0302 clinical medicine[SDV.CAN] Life Sciences [q-bio]/Cancerimmune system diseasesInternal medicinehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansHypoalbuminemiaeducationSerum Albumin030304 developmental biologyCause of deathRetrospective StudiesAged 80 and over0303 health scienceseducation.field_of_studypalliative carebusiness.industryIncidence (epidemiology)IncidenceLymphoma Non-HodgkinHematologymedicine.diseasePrognosisComorbidity3. Good healthLymphomaSurgeryaged 80 and overcomorbidityOncology030220 oncology & carcinogenesisFemaleLymphoma Large B-Cell DiffusebusinessDiffuse large B-cell lymphoma
researchProduct

Permanent stenting in “unextractable” common bile duct stones in high risk patients. A prospective randomized study comparing two different stents

2007

BACKGROUND: Endoscopic sphincterotomy (ES) and stone extraction is the treatment of choice for bile duct stones. Therefore, if ES and conventional stone extraction fail, further treatment is mandatory. Insertion of a biliary endoprosthesis is an effective option. MATERIALS AND METHODS: We treated 30 high-risk patients (17 women and 13 men, mean age 82 years) affected by difficult common bile duct stones. The patients were randomly assigned preoperatively using closed envelopes (blind randomization) into two groups to receive insertion of polyethylene or hydrophilic hydromer-coated polyurethane stent, respectively. Follow-up was achieved by contacting referring physicians and patient's relat…

Malemedicine.medical_specialtyPalliative caremedicine.medical_treatmentPolyurethanesComorbidityGallstonesSphincterotomy EndoscopicPostoperative ComplicationsCoated Materials BiocompatibleLiver Function TestsCholestasisRisk FactorsCause of DeathmedicineHumansAgedAged 80 and overCholangiopancreatography Endoscopic RetrogradePermanent stenting difficult stones prospective study stentsCommon bile ductBile ductbusiness.industryPalliative CarePovidoneStentEquipment DesignCholestasis ExtrahepaticVascular surgerymedicine.diseaseSettore MED/18 - Chirurgia Generalemedicine.anatomical_structurePolyethyleneCardiothoracic surgeryEquipment FailureFemaleStentsSurgeryRadiologybusinessFollow-Up StudiesIsocyanatesAbdominal surgeryLangenbeck's Archives of Surgery
researchProduct

Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-α in pancreatic and periampullary cancer: Results of a feasibility study

2008

Abstract Background Recent studies give rise to the hypothesis, that adjuvant chemoradioimmunotherapy with 5-fluorouracil (5-FU), cisplatin and interferon-α (IFN-α) might be a possible new treatment of pancreatic cancer in resected patients. We report the up-to-now experience at our institution. Patients and methods Eleven patients with histological diagnosis of localized carcinoma of the pancreas ( n  = 7) or periampullary ( n  = 4) were prospectively analyzed. Four patients were deemed unresectable because of local invasion of adjacent organs (neoadjuvant setting) and seven patients underwent curative resection (adjuvant setting). Eight patients were classified as T3 carcinomas and three …

Malemedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentAntineoplastic AgentsRisk AssessmentGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinePancreatic cancermedicinePeriampullary cancerHumansNeoplasm InvasivenessRadiology Nuclear Medicine and imagingSurvival rateNeoplasm Staging030304 developmental biology0303 health sciencesbusiness.industryPatient SelectionRadiotherapy Dosagemedicine.diseaseCombined Modality Therapypeople.cause_of_deathRecombinant Proteins3. Good healthSurgeryPancreatic NeoplasmsSurvival RateRadiation therapyOncology030220 oncology & carcinogenesisConcomitantInterferon Type IFeasibility StudiesFemaleFluorouracilImmunotherapyCisplatinbusinesspeopleChemoradiotherapyProgressive diseaseCancer/Radiothérapie
researchProduct

Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients.

2006

Coronary artery disease (CAD) is characterized by an inflammatory status and it represents the major cause of death in elderly. Zinc deficiency and inflammatory genes within major histocompatibility complex (MHC) region are implicated in ischaemic heart diseases. TNF-alpha is present in coronary artery plaques and may provoke plaque instability. Hsp70 plays instead a pro-atherogenic role, via proinflammatory cytokine production, in atherosclerotic lesions contributing to plaque rupture. Contradictory data report the association between -308 TNF-alpha polymorphism and CAD, while no investigations exist on Hsp70-2 gene in CAD. In the current study, we analysed -308 TNF-alpha and 1267 Hsp70-2 …

Malemedicine.medical_specialtyPathologyAgingCoronary Artery DiseaseMajor histocompatibility complexGastroenterologyRisk AssessmentProinflammatory cytokineCoronary artery diseaseGene FrequencyRisk FactorsInternal medicineGenotypemedicineOdds RatioHumansCarotid StenosisGenetic Predisposition to DiseaseHSP70 Heat-Shock ProteinsAlleleCause of deathAgedPolymorphism Geneticbiologybusiness.industryInterleukin-6Tumor Necrosis Factor-alphaMiddle Agedmedicine.diseaseZincmedicine.anatomical_structureHaplotypesItalyCase-Control Studiesbiology.proteinTumor necrosis factor alphaFemaleGeriatrics and GerontologybusinessGerontologyBiomarkersArteryBiogerontology
researchProduct

The Jervell and Lange-Nielsen syndrome.

1991

Deafness and electrocardiographic changes (prolongation of the Q-T interval and inversion of the T wave) with a clinical picture of syncopal attacks and sudden death, were described as a distinct syndrome by Jervell and Lange-Nielsen in 1957. The syndrome is inherited as an autosomal recessive trait. In this study, all the cases reported since 1957 and their proposed prevalence are reviewed. The authors describe the 4 cases they have studied, all of which presented congenital sensorineural hearing loss and electrocardiographic changes characteristic of the syndrome. The relatively high number of cases they have encountered casts doubt on literature that states that the syndrome occurs more …

Malemedicine.medical_specialtyPediatricsHeart diseaseElectrodiagnosisDeafnessSudden deathAutosomal recessive traitElectrocardiographyAudiometryLange-nielsen syndromemedicineCongenital sensorineural hearing lossHumansmedicine.diagnostic_testbusiness.industryInfantGeneral Medicinemedicine.diseaseSurgeryJervell and Lange-Nielsen syndromeLong QT SyndromeOtorhinolaryngologyPediatrics Perinatology and Child HealthFemalebusinessElectrocardiographyInternational journal of pediatric otorhinolaryngology
researchProduct